Media Watch
Tag:
FDA-approved HIV Prophylactic welcomed
South African HIV clinicians have welcomed an announcement that the US Food and Drug Administration (FDA) has approved the use of an antiretroviral by sexually active HIV-negative men and women as a method of reducing the risk of HIV infection in adults.The Times offers a valuable platform for discussion
An op-ed piece in Monday’s edition of The Times draws much-needed attention to the role of behaviour change in HIV prevention.
Recent breakthroughs in the science and medicine of HIV treatment and prevention have meant that much of the media’s attention has been fixed firmly on the development of microbicide gels, the advent of pre-exposure prophylaxis (Prep), rollout of medical male circumcision and the accessibility of post-exposure prophylaxis (PEP).
Whilst these are all firm and promising steps towards stemming the spread of the virus, behaviour change remains an important component in addressing and redressing the spread of HIV.
Bad reporting: Revealing the real scourge
An error ridden article by the South African Press Association (SAPA) has been used by various newspapers to report on a particular HIV-related landmark development.Page 1 of 1 pages
